QSimulate, a portfolio company of Abies Ventures, was featured in Nikkei Crosstech for innovative technology in the field of quantum chemical simulation.
Mar. 31, 2025
- News
QSimulate, a portfolio company of Abies Ventures, is driving innovation in quantum chemical simulation, advancing the digital transformation (DX) of research and development (R&D) in pharmaceutical, materials and chemical companies. The company’s QSP platform provides a user-friendly environment for conducting state-of-the-art quantum chemistry simulations, and enhances the efficiency and sophistication of R&D.
QSimulate is also collaborating with JSR Corporation to develop and refine high-precision databases in the field of Materials Informatics (MI). Furthermore, through a strategic partnership with Japan Tobacco Inc (JT), QSimulate is advancing AI-driven drug discovery with the aim of accelerating new drug development.
Through these efforts, QSimulate is democratizing access to quantum chemistry simulation and helping pharmaceutical and materials companies accelerate their R&D.
For more information, please click on the link below. (Japanese Newsletter)